Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer

DOI: 10.5306/wjco.v9.i8.172

Keywords: Hormone receptor positive/Her2-negative breast cancer, PI3K, mTOR, TORC1/2, Akt, Everolimus

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text